Similar articles

• Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.

  Hackam DG, Anand SS. Hackam DG, et al. JAMA. 2003 Aug 20;290(7):932-40. doi: 10.1001/jama.290.7.932. JAMA. 2003. PMID: 12928471 Review.
• Novel risk factors for atherosclerosis.

  Kullo IJ, Gau GT, Tajik AJ. Kullo IJ, et al. Mayo Clin Proc. 2000 Apr;75(4):369-80. doi: 10.4065/75.4.369. Mayo Clin Proc. 2000. PMID: 10761492 Review.
• Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients.

  Massy ZA. Massy ZA. Nephrol Dial Transplant. 2000;15 Suppl 5:81-91. doi: 10.1093/ndt/15.suppl_5.81. Nephrol Dial Transplant. 2000. PMID: 11073279 Review. No abstract available.
• Homocysteinemia: new information about an old risk factor for vascular disease.

  Engman M. Engman M. J Insur Med. 1998;30(4):231-6. J Insur Med. 1998. PMID: 10537928 Review.
• Elevated plasma homocysteine as a risk factor for atherosclerosis.

  Taylor LM Jr, Porter JM. Taylor LM Jr, et al. Semin Vasc Surg. 1993 Mar;6(1):36-45. Semin Vasc Surg. 1993. PMID: 8252227 Review. No abstract available.